|Podcasts|June 30, 2022
Managed Care Cast Presents: ILD Peer Exchange—Treatment Goals in ILD, Part 1
In part 1 of this 2-part podcast, a panel of experts discusses treatment goals in patients with interstitial lung disease (ILD) and reviews of treatment paradigms and standard of care therapies
Advertisement
Today we are bringing you part 1 of a 2-part sponsored podcast series discussing treatment goals in insterstitial lung disease (ILD). The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.
The topics of conversation for today’s podcast include treatment goals in patients with ILD and a review of treatment paradigms and standard of care therapies.
Listen above or through one of these podcast services:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
2
INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD
3
First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD
4
AI Reshaping Diabetes Care From Nutrition to Clinical Decisions
5